Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy with few available targeted therapies. We previously reported that the phosphatase calcineurin (Cn) is required for LIC (leukemia Initiating Capacity) potential of T-ALL pointing to Cn as an interesting therapeutic target. Calcineurin inhibitors have however unwanted side effect. NFAT transcription factors play crucial roles downstream of calcineurin during thymocyte development, T cell differentiation, activation and anergy. Here we elucidate NFAT functional relevance in T-ALL. Using murine T-ALL models in which Nfat genes can be inactivated either singly or in combination, we show that NFATs are required for T-ALL LIC potential and essential to survival, proliferation and migration of T-ALL cells. We also demonstrate that Nfat genes are functionally redundant in T-ALL and identified a node of genes commonly deregulated upon Cn or NFAT inactivation, which may serve as future candidate targets for T-ALL.

Highlights

  • T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy of T-cell progenitors that represents about 15% of pediatric and 25% of adult acute lymphoblastic leukemia cases

  • We found that constitutive deletion of the Nfat1 gene did not affect T-ALL onset in both the transgenic TEL-JAK2 and in the bone marrow (BM) transplantation model of in mice by activated NOTCH1 (ICN1)-induced T-ALL (S1 Fig), suggesting either no function or a redundant of Nfat genes in T-ALL

  • We demonstrate that the three NFAT factors activated in T-ALL, namely NFAT1, 2 and 4 are essential to the survival/proliferation/migration properties and leukemia propagating potential of T-ALL

Read more

Summary

Introduction

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy of T-cell progenitors that represents about 15% of pediatric and 25% of adult acute lymphoblastic leukemia cases. Genome-wide transcriptional profiling analysis enabled to classify T-ALL into different molecular subgroups characterized by abnormal expression of several transcription factors including TAL1/2, LMO1/2, TLX1/3, NKX2.1/2.2, HOXA, as the result of genetic rearrangements or other modes of deregulation (for review [1]). Another T-ALL subgroup encompasses cases characterized by a transcriptional signature resembling that of early T cell progenitors (ETP subgroup).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call